Identification of an IDO1‐based immune classifier for survival prediction of upper tract urothelial carcinoma

The limited response rate of immunotherapy in upper tract urothelial carcinoma (UTUC) might be attributed to additional immunosuppressive mechanisms in vivo. As a promising immune checkpoint target, the expression and prognostic role of indoleamine 2,3‐dioxygenase 1 (IDO1) in UTUC remains unknown. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Wenlong, Yang, Meng, Cheng, Sida, Hou, Weibin, Wang, Bo, Chen, Junyu, Yu, Hao, Ouyang, Yi, Wang, Xiaofei, Ou, Ziwei, Xu, Peiqi, Li, Xuesong, Zhou, Liqun, Huang, Jian, Wang, Chunhui, Lin, Tianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898711/
https://www.ncbi.nlm.nih.gov/pubmed/34962030
http://dx.doi.org/10.1111/cas.15253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898711/
https://www.ncbi.nlm.nih.gov/pubmed/34962030
http://dx.doi.org/10.1111/cas.15253

Ejemplares similares